OBI Pharma, Inc. (TPEX:4174)
Taiwan · Delayed Price · Currency is TWD 30.20
+0.60 (2.03%)
At close: Jul 9, 2026
OBI Pharma Market Cap
OBI Pharma has a market cap or net worth of 3.97 billion as of July 9, 2026. Its market cap has decreased by -56.33% in one year.
Market Cap
3.97B
Enterprise Value
4.41B
Revenue
49.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.20
Market Cap Chart
Since December 12, 2012, OBI Pharma's market cap has decreased from 16.87B to 3.97B, a decrease of -76.44%. That is a compound annual growth rate of -10.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 3.97B | -44.03% |
| Dec 31, 2025 | 7.10B | -53.86% |
| Dec 31, 2024 | 15.39B | -3.28% |
| Dec 29, 2023 | 15.91B | 0.50% |
| Dec 30, 2022 | 15.83B | -30.20% |
| Dec 30, 2021 | 22.68B | -13.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Steminent Biotherapeutics | 4.93B |
| Pharmosa Biopharm | 4.91B |
| Senhwa Biosciences | 3.91B |
| Genovate Biotechnology | 3.88B |
| Formosa Pharmaceuticals | 3.74B |
| Sagittarius Life Science | 3.53B |
| SYN-TECH Chem. & Pharm. | 3.29B |
| Energenesis Biomedical CO.,LTD. | 3.23B |